Holen Sie sich die Stockscreener-App
11.65
0.95%
0.11
Schlusskurs vom Vortag:
$11.54
Offen:
$11.4081
24-Stunden-Volumen:
13,277
Relative Volume:
0.19
Marktkapitalisierung:
$106.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-41.01%
1M Leistung:
-53.02%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$11.41
$11.75
1-Wochen-Bereich:
$11.00
$17.90
52-Wochen-Spanne:
$10.24
$33.50
Research Alliance Corp Iii Stock (RACC) Company Profile
Firmenname
Research Alliance Corp Iii
Sektor
Branche
Telefon
(617) 778-2500
Adresse
600 FIFTH AVENUE, 23RD FLOOR, NEW YORK
Compare RACC vs LION, XXI, UMAC, CCXI, DMII
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RACC
Research Alliance Corp Iii
|
11.65 | 105.00M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
11.03 | 3.32B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.72 | 3.30B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
24.95 | 1.30B | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
13.60 | 757.52M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.21 | 647.51M | 0 | 8.58M | -1.11M | 0.134 |
Research Alliance Corp Iii Aktie (RACC) Neueste Nachrichten
Latus Bio Names Donald Hayden Chairman, Adds Michael MacLean to Board - citybiz
Health and care sector latest developments - The NHS Alliance
Research Alliance Corp II (RACB) Key Ratios - Value Research
Research Alliance Corporation III Class A Ordinary Shares (NASDAQ: RACC) Stock Price, News & Analysis - Kalkine
Kazakhstan envisions at least 2.4 gigawatts of nuclear power by 2035. TGI Solar plans a tech base there. - Stock Titan
Research Alliance Corp II (RACB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Top Premarket Decliners - Moomoo
Research Alliance Corp II (RACB) Peer Comparison – Compare with Others - Value Research
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology - The American Journal of Managed Care
Research Alliance Corporation III (RACC) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Lupus Research Alliance Awards More Than $2 Million to Study the Power of Lifestyle Interventions - Yahoo Finance
Top Research Alliance Corporation III (RACC) Competitors 2026 - MarketBeat
Research Alliance Holdings Iv Llc Net Worth (2026) - GuruFocus
Balyasny Asset Management L.P. Acquires 500,000 Shares of Resear - GuruFocus
Research Alliance Corporation III (RACC) Institutional Ownership 2026 - MarketBeat
Research Alliance Corp IV Q2 2026: Net income $(41,013), EPS $(0.03) — 10-Q Summary - TradingView
Research Alliance Corp IV (RACD) starts 24‑month clock to deploy $75M SPAC cash - Stock Titan
United Launch Alliance's new CEO and more leadership moves across the market - Washington Technology
Research Alliance Corporation III (RACC) Stock Trends and Sentiment 2026 - MarketBeat
RACD: Research Alliance Corporation IVInteractive ChartZacks.com - Zacks Investment Research
Research Alliance Corporation III (RACC) Earnings Date and Reports 2026 - MarketBeat
Research Alliance Corporation III Reports Earnings Results for the Four and Six Months Ended June 30, 2026 - marketscreener.com
What is the current Price Target and Forecast for Research Alliance Corporation III (RACC) - Zacks Investment Research
All News for RACD : Research Alliance Corporation IV - Zacks Investment Research
8/3/2026 Market UpdateWinners: AEMD, HYFM, DFNSLosers: INHD, GYGY, CALCS&P 500: 1.5% - Trefis
AI Leaders Propose SAFE Guidelines for Cybersecurity Transparency - NVIDIA Blog
Should I buy Research Alliance Corporation IV (RACD) - Zacks Investment Research
RACD Technical Analysis & Stock Price Forecast - Intellectia AI
7/30/2026 Market UpdateWinners: CYCU, GCTK, NUWELosers: MGRX, CCB, YYAIS&P 500: 1.7% - Trefis
PEMC, PERPI launch three-year research partnership on electricity market - Daily Tribune
Oak Hill takes SPAC track to Nasdaq with Roche asset in tow - BioSpace
OHB Pediatrics Ltd. entered into a definitive business combination agreement to acquire Research Alliance Corporation III from Research Alliance Holdings III LLC and others for approximately $160 million in a reverse merger transaction. - marketscreener.com
RA Capital launches Oak Hill Bio onto the Nasdaq via SPAC - fiercebiotech.com
OHB Pediatrics to go public through Research Alliance Corporation III pact - TipRanks
Oak Hill Bio goes public with ~$175M in proceeds - The Pharma Letter
RA Capital-backed SPAC Research Alliance Corp III agrees to merge with Oak Hill Bio in USD 175 million deal - Bitget
Sierra Bancorp Q2 FY26 net income falls 7% to $9.9 million; revenue dips 1% to $39 million - Bitget
Iberdrola secures EUR 29 million EIB green loan for Labraza wind farm development - Bitget
Form 4 Research Alliance Corporation III For: 27 July By Investing.com - Investing.com Nigeria
EDGAR Filing Documents for 0001193125-26-316960 - SEC.gov
EDGAR Filing Documents for 0001193125-26-316954 - SEC.gov
Research Alliance to Acquire OHB Pediatrics in Stock Deal Valued at $160 Million Plus SAFEs - TradingView
Oak Hill Bio, Research Alliance III (RACC) plan SPAC merger - Stock Titan
Oak Hill Bio and Research Alliance Corporation III Announce - GlobeNewswire
Industry Leaders Unite in Open Secure AI Alliance for AI Safety and Security - NVIDIA Blog
RACC|Research Alliance III Ord Shs Class A|Price:11.000|Chg%:-0.250 - TradingKey
Research Alliance Corporation IV Revenue Breakdown – NASDAQ:RACD - TradingView
Enterprise value to revenue forward of Research Alliance Corporation III – NASDAQ:RACC - TradingView
Meridia RE IV Socimi announces EUR 0.01 per share dividend for 2025 results - Bitget
COMMODORE CAPITAL LP Acquires 500,000 Shares in Research Alliance Corp IV - GuruFocus
Wesfarmers Price Target Raised 2% to A$88.00/Share by Macquarie - Bitget
Finanzdaten der Research Alliance Corp Iii-Aktie (RACC)
Es liegen keine Finanzdaten für Research Alliance Corp Iii (RACC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):